Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
Title:
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
Author:
Van Cutsem, E. Boni, C. Tabernero, J. Massuti, B. Middleton, G. Dane, F. Reichardt, P. Pimentel, F.L. Cohn, A. Follana, P. Clemens, M. Zaniboni, A. Moiseyenko, V. Harrison, M. Richards, D.A. Prenen, H. Pernot, S. Ecstein-Fraisse, E. Hitier, S. Rougier, P.